Article Text
Abstract
Purpose To explore parental perceptions and experiences regarding the return of genomic incidental research findings in children with rare diseases.
Methods Parents of children affected by various rare diseases were invited to participate in focus groups or individual telephone interviews in Montreal and Ottawa. Fifteen participants were interviewed and transcriptions were analysed using thematic analysis.
Results Four emergent themes underscored parental enthusiasm for receiving incidental findings concerning their child's health: (1) right to information; (2) perceived benefits and risks; (3) communication practicalities: who, when, and how; and (4) service needs to promote the communication of incidental findings. Parents believed they should be made aware of all results pertaining to their child's health status, and that they are responsible for transmitting this information to their child, irrespective of disease severity. Despite potential negative consequences, respondents generally perceived a favourable risk-benefit ratio in receiving all incidental findings.
Conclusions Understanding how parents assess the risks and benefits of returning incidental findings is essential to genomic research applications in paediatric medicine. The authors believe the study findings will contribute to establishing future best practices, although further research is needed to evaluate the impact of parental decisions on themselves and their child.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Statistics from Altmetric.com
Other content recommended for you
- The return of individual research findings in paediatric genetic research
- Return of participant-level clinical trial results to participants: pilot of a simplified centralised approach
- Attitudes of African-American parents about biobank participation and return of results for themselves and their children
- Why do parents enrol their children in research: a narrative synthesis
- Evidence of broad-based family support for the use of archival childhood tumour samples in future research
- Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania
- Gene therapy for children with cystic fibrosis—who has the right to choose?
- Preschoolers’ parent-rated health disparities are strongly associated with measures of adiposity in the Lifeways cohort study children
- Defining and managing incidental findings in genetic and genomic practice
- Pilot evaluation of parental and professional views regarding consent in neonatal medicine by telephone interviews and questionnaires